Literature DB >> 23328439

Impairment of spinal motor neurons in spinocerebellar ataxia type 1-knock-in mice.

Yasuhiko Takechi1, Tokue Mieda, Akira Iizuka, Syutaro Toya, Nana Suto, Kenji Takagishi, Yoichi Nakazato, Kazuhiro Nakamura, Hirokazu Hirai.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused by the expansion of polyglutamine repeats in the Ataxin-1 protein. An accumulating body of cerebellar, histological and behavioral analyses has proven that SCA1-knock-in mice (in which the endogenous Atxn1 gene is replaced with mutant Atxn1 that has abnormally expanded 154 CAG repeats) work as a good tool, which resembles the central nervous system pathology of SCA1 patients. However, the peripheral nervous system pathology of the model mice has not been studied despite the fact that the clinical manifestation is also characterized by peripheral involvement. We show here that spinal motor neurons are degenerated in SCA1-knock-in mice. Histologically, some spinal motor neurons of the SCA1-knock-in mice have polyglutamine aggregates in their nuclei and also thinner and demyelinated axons. Electrophysiological examinations of the mice showed slower nerve conduction velocities in spinal motor neurons and lower amplitudes of muscle action potential, compared to wild-type mice. Consistently, the mice displayed decrease in rearing number and total rearing time. These results suggest that the knock-in mice serve as a definite model that reproduces peripheral involvement and are therefore useful for research on the peripheral nervous system pathology in SCA1 patients.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23328439     DOI: 10.1016/j.neulet.2012.12.057

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  The HERC1 E3 Ubiquitin Ligase is essential for normal development and for neurotransmission at the mouse neuromuscular junction.

Authors:  S Bachiller; T Rybkina; E Porras-García; E Pérez-Villegas; L Tabares; J A Armengol; A M Carrión; R Ruiz
Journal:  Cell Mol Life Sci       Date:  2015-03-08       Impact factor: 9.261

Review 2.  The extra-cerebellar effects of spinocerebellar ataxia type 1 (SCA1): looking beyond the cerebellum.

Authors:  Victor Olmos; Neha Gogia; Kimberly Luttik; Fatema Haidery; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2022-07-08       Impact factor: 9.207

3.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

Review 4.  Pathogenic mechanisms underlying spinocerebellar ataxia type 1.

Authors:  Leon Tejwani; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2020-04-18       Impact factor: 9.261

5.  Spontaneous functional full recovery from motor and sensory deficits in adult mice after mild spinal cord injury.

Authors:  Yohei Kakuta; Anna Adachi; Marino Yokohama; Toshiki Horii; Tokue Mieda; Yoichi Iizuka; Kenji Takagishi; Hirotaka Chikuda; Haku Iizuka; Kazuhiro Nakamura
Journal:  Heliyon       Date:  2019-06-02

6.  Reduction of mutant ATXN1 rescues premature death in a conditional SCA1 mouse model.

Authors:  James P Orengo; Larissa Nitschke; Meike E van der Heijden; Nicholas A Ciaburri; Harry T Orr; Huda Y Zoghbi
Journal:  JCI Insight       Date:  2022-04-22

7.  Motor neuron degeneration correlates with respiratory dysfunction in SCA1.

Authors:  James P Orengo; Meike E van der Heijden; Shuang Hao; Jianrong Tang; Harry T Orr; Huda Y Zoghbi
Journal:  Dis Model Mech       Date:  2018-02-26       Impact factor: 5.758

8.  Xenografting of human umbilical mesenchymal stem cells from Wharton's jelly ameliorates mouse spinocerebellar ataxia type 1.

Authors:  Pei-Jiun Tsai; Chang-Ching Yeh; Wan-Jhen Huang; Ming-Yuan Min; Tzu-Hao Huang; Tsui-Ling Ko; Pei-Yu Huang; Tien-Hua Chen; Sanford P C Hsu; Bing-Wen Soong; Yu-Show Fu
Journal:  Transl Neurodegener       Date:  2019-09-05       Impact factor: 8.014

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.